AGP Picks
View all

The France Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The France Journal.

Press releases published on July 22, 2026

Tellurian Research lance ses services d'intelligence stratégique en République démocratique du Congo
Click Bond Expands Viba Aerospace & Defense Representation into France
MUSASHI JAPAN Opens First Overseas Store in Paris, Expanding Its Japanese Kitchen Knife Retail Presence in Europe
ABL Diagnostics désignée par le Tribunal de commerce d'Évry pour la reprise des activités de TEXCELL
ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL’s Operations
European Union 'Article 28 Standard' - Anti-Money Laundering Regulation (AMLR)
Soitec Reports First Quarter Revenue of Fiscal Year 2027
Soitec Publie Le Chiffre d'Affaires Du Premier Trimestre De Son Excercice Fiscal 2027
Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026
Valneva publiera ses résultats financiers consolidés du premier semestre le 13 août 2026
Ipsos: Significant activity rebound in the second quarter
Ipsos : Net rebond de l’activité au 2ème trimestre
Sodexo selected by Clariant to deliver global integrated workplace services
Sodexo retenu pour gérer l’ensemble des sites de Clariant dans le monde
VALLOUREC REMPORTE UN CONTRAT AUPRÈS D’ALLSEAS POUR LE PROJET OFFSHORE ATAPU 2 AU BRÉSIL
VALLOUREC WINS A CONTRACT WITH ALLSEAS FOR ATAPU 2 OFFSHORE PROJECT IN BRAZIL
Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen's Rare Disease pipeline
Ipsen finalise l'acquisition de Memo Therapeutics AG, ajoutant un actif premier de sa classe au portefeuille de maladies rares d'Ipsen

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The France Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.